Intensification to biphasic insulin aspart 30/70 (BIAsp 30, NovoMix® 30) can improve glycaemic control in patients treated with basal insulins: a subgroup analysis of the IMPROVE™ observational study

Summary Aims: The international IMPROVE™ observational study investigated the safety profile and effectiveness of biphasic insulin aspart 30/70 (BIAsp 30) in the routine treatment of patients with type 2 diabetes. We present analyses for the subgroup of patients who switched from basal insulin to B...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of clinical practice (Esher) 2009-06, Vol.63 (6), p.966-972
Hauptverfasser:	Gumprecht, J., Benroubi, M., Borzi, V., Kawamori, R., Shaban, J., Shah, S., Shestakova, M., Wenying, Y., Ligthelm, R., Valensi, P.
Format:	Artikel
Sprache:	eng
Schlagworte:	Biphasic Insulins Blood Glucose - metabolism Blood tests Comparative studies Diabetes Diabetes Mellitus, Type 2 - blood Diabetes Mellitus, Type 2 - drug therapy Disease management Female Glycated Hemoglobin - metabolism Humans Hypoglycemia - chemically induced Hypoglycemic Agents - administration & dosage Hypoglycemic Agents - adverse effects Insulin Insulin - administration & dosage Insulin - adverse effects Insulin - analogs & derivatives Insulin Aspart Insulin, Isophane Late Breakers Male Middle Aged Patient Satisfaction Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!